Brian Cheng
Stock Analyst at J.P. Morgan
(4.56)
# 994
Out of 4,646 analysts
273
Total ratings
54.5%
Success rate
14.5%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Maintained: Buy | $113 → $149 | $153.43 | -2.89% | 23 | Aug 12, 2026 | |
| STTK Shattuck Labs | Maintained: Buy | $10 → $13 | $7.47 | +74.03% | 2 | Aug 12, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $65 → $72 | $48.49 | +48.48% | 4 | Aug 10, 2026 | |
| IMVT Immunovant | Maintained: Buy | $50 | $42.53 | +17.56% | 13 | Aug 10, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $40 | $36.19 | +10.53% | 25 | Aug 10, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintained: Buy | $31 → $27 | $16.12 | +67.49% | 3 | Aug 10, 2026 | |
| ODTX Odyssey Therapeutics | Maintained: Buy | $26 → $29 | $21.06 | +37.70% | 2 | Aug 10, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $205 → $227 | $205.51 | +10.46% | 16 | Aug 7, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $95 → $100 | $87.28 | +14.58% | 4 | Aug 6, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $44 | $26.77 | +64.36% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $113.69 | +6.43% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $25.73 | +78.78% | 1 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 → $91 | $72.45 | +25.60% | 10 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.93 | - | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.27 | - | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.52 | - | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $11.98 | -33.22% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $8.07 | +259.36% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $14 | $22.79 | -38.57% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $76.24 | +25.92% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $2.06 | - | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $46 | $19.19 | +139.71% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.89 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.48 | - | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $67 | $53.78 | +24.58% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.09 | - | 2 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.40 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $9.32 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $6.67 | - | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.06 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.30 | n/a | 7 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.16 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.24 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $8.43 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.3765 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.1705 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $3.5 | $1.90 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $10.00 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.9785 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $86 | $8.07 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.17 | n/a | 2 | Nov 2, 2021 |
Protagonist Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $113 → $149
Current: $153.43
Upside: -2.89%
Shattuck Labs
Aug 12, 2026
Maintained: Buy
Price Target: $10 → $13
Current: $7.47
Upside: +74.03%
TG Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $65 → $72
Current: $48.49
Upside: +48.48%
Immunovant
Aug 10, 2026
Maintained: Buy
Price Target: $50
Current: $42.53
Upside: +17.56%
Roivant Sciences
Aug 10, 2026
Maintained: Buy
Price Target: $40
Current: $36.19
Upside: +10.53%
Monte Rosa Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $31 → $27
Current: $16.12
Upside: +67.49%
Odyssey Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $26 → $29
Current: $21.06
Upside: +37.70%
Revolution Medicines
Aug 7, 2026
Maintained: Buy
Price Target: $205 → $227
Current: $205.51
Upside: +10.46%
Arrowhead Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $95 → $100
Current: $87.28
Upside: +14.58%
Beam Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $44
Current: $26.77
Upside: +64.36%
Aug 6, 2026
Maintained: Buy
Price Target: $121
Current: $113.69
Upside: +6.43%
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $25.73
Upside: +78.78%
Jul 13, 2026
Maintained: Buy
Price Target: $89 → $91
Current: $72.45
Upside: +25.60%
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $3.93
Upside: -
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $27.27
Upside: -
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $10.52
Upside: -
May 13, 2026
Maintained: Sell
Price Target: $8
Current: $11.98
Upside: -33.22%
May 13, 2026
Rated: Buy
Price Target: $29
Current: $8.07
Upside: +259.36%
May 11, 2026
Rated: Hold
Price Target: $13 → $14
Current: $22.79
Upside: -38.57%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $76.24
Upside: +25.92%
Apr 16, 2026
Upgraded: Hold
Price Target: n/a
Current: $2.06
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: $47 → $46
Current: $19.19
Upside: +139.71%
Mar 13, 2026
Maintained: Sell
Price Target: n/a
Current: $2.89
Upside: -
Mar 3, 2026
Maintained: Buy
Price Target: n/a
Current: $25.48
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $69 → $67
Current: $53.78
Upside: +24.58%
Dec 4, 2025
Reiterated: Sell
Price Target: n/a
Current: $1.09
Upside: -
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.40
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $9.32
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $6.67
Upside: -
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Sep 13, 2024
Rated: Hold
Price Target: n/a
Current: $3.30
Upside: n/a
Jul 15, 2024
Maintained: Hold
Price Target: n/a
Current: $1.16
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.24
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $8.43
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.3765
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.1705
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: $33 → $3.5
Current: $1.90
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $10.00
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.9785
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $93 → $86
Current: $8.07
Upside: n/a
Nov 2, 2021
Maintained: Buy
Price Target: $14
Current: $2.17
Upside: n/a